Cargando…

Hemoglobin overexpression and splice signature as new features of inflammatory breast cancer?

INTRODUCTION: Inflammatory Breast Cancer (IBC) is the most aggressive form of breast carcinoma characterized by rapid onset of inflammatory signs and its molecular fingerprint has not yet been elucidated. OBJECTIVES: The objective of this study was to detect both gene expression levels and alternate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lerebours, F., Vacher, S., Guinebretiere, J.M., Rondeau, S., Caly, M., Gentien, D., Van Laere, S., Bertucci, F., de la Grange, P., Bièche, l., Liang, X., Callens, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753232/ https://www.ncbi.nlm.nih.gov/pubmed/33364047 http://dx.doi.org/10.1016/j.jare.2020.08.009

Ejemplares similares

Altered Expression of Three EGFR Posttranslational Regulators MDGI, MIG6, and EIG121 in Invasive Breast Carcinomas
por: Meseure, Didier, et al.
Publicado: (2020)

Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer
por: Liang, Xu, et al.
Publicado: (2018)

ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels
por: Rondeau, S, et al.
Publicado: (2015)

Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer
por: Tury, Sandrine, et al.
Publicado: (2016)

MED12 mutations in breast phyllodes tumors: evidence of temporal tumoral heterogeneity and identification of associated critical signaling pathways
por: Laé, Marick, et al.
Publicado: (2016)

Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer
por: Meseure, Didier, et al.
Publicado: (2016)

NF-kappa B genes have a major role in Inflammatory Breast Cancer
por: Lerebours, Florence, et al.
Publicado: (2008)

MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?
por: Cizeron-Clairac, Geraldine, et al.
Publicado: (2015)

Expression analysis of mitotic spindle checkpoint genes in breast carcinoma: role of NDC80/HEC1 in early breast tumorigenicity, and a two-gene signature for aneuploidy
por: Bièche, Ivan, et al.
Publicado: (2011)

KRAS mutation status in colorectal cancer to predict response to EGFR targeted therapies: the need for a more precise definition
por: Rouleau, E, et al.
Publicado: (2008)

A short-term colorectal cancer sphere culture as a relevant tool for human cancer biology investigation
por: Weiswald, L-B, et al.
Publicado: (2013)

HORMAD1 overexpression predicts response to anthracycline–cyclophosphamide and survival in triple‐negative breast cancers
por: El‐Botty, Rania, et al.
Publicado: (2023)

Update on inflammatory breast cancer
por: Lerebours, Florence, et al.
Publicado: (2005)

High Positive Correlations between ANRIL and p16-CDKN2A/p15-CDKN2B/p14-ARF Gene Cluster Overexpression in Multi-Tumor Types Suggest Deregulated Activation of an ANRIL–ARF Bidirectional Promoter
por: Drak Alsibai, Kinan, et al.
Publicado: (2019)

In1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive features
por: Ibáñez-Costa, Alejandro, et al.
Publicado: (2015)

Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna(®) Test in the management of early-stage breast cancers
por: Hequet, Delphine, et al.
Publicado: (2017)

Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma
por: Rossi, L, et al.
Publicado: (2015)

PIK3R1 underexpression is an independent prognostic marker in breast cancer
por: Cizkova, Magdalena, et al.
Publicado: (2013)

Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay
por: Mouttet, D., et al.
Publicado: (2016)

An update on biomarkers of potential benefit with bevacizumab for breast cancer treatment: Do we make progress?
por: Liang, Xu, et al.
Publicado: (2019)

Clinical value of R-spondins in triple-negative and metaplastic breast cancers
por: Coussy, F, et al.
Publicado: (2017)

MDA-MB-231 breast cancer cells overexpressing single VEGF isoforms display distinct colonisation characteristics
por: Di Benedetto, Melanie, et al.
Publicado: (2015)

ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin
por: Tanaka, Iris, et al.
Publicado: (2020)

Overexpression of Vitreoscilla hemoglobin increases waterlogging tolerance in Arabidopsis and maize
por: Du, Hewei, et al.
Publicado: (2016)

Acquired Exon 14 MET Mutation Associated With Resistance to Alectinib in a Patient With ALK–Rearranged NSCLC
por: Daniel, Catherine, et al.
Publicado: (2020)

Importance of pre-analytical steps for transcriptome and RT-qPCR analyses in the context of the phase II randomised multicentre trial REMAGUS02 of neoadjuvant chemotherapy in breast cancer patients
por: de Cremoux, Patricia, et al.
Publicado: (2011)

Similar NF-κB Gene Signatures in TNF-α Treated Human Endothelial Cells and Breast Tumor Biopsies
por: Perrot-Applanat, Martine, et al.
Publicado: (2011)

Complex splicing pattern generates great diversity in human NF1 transcripts
por: Vandenbroucke, Ina, et al.
Publicado: (2002)

Splicing-associated chromatin signatures: a combinatorial and position-dependent role for histone marks in splicing definition
por: Agirre, E., et al.
Publicado: (2021)

HAX-1 overexpression, splicing and cellular localization in tumors
por: Trebinska, Alicja, et al.
Publicado: (2010)

Overexpression and alternative splicing of NF-YA in breast cancer
por: Dolfini, Diletta, et al.
Publicado: (2019)

Heterologous overexpression of bacterial hemoglobin VHb improves erythritol biosynthesis by yeast Yarrowia lipolytica
por: Mirończuk, Aleksandra M., et al.
Publicado: (2019)

The consensus sequence of FAMLF alternative splice variants is overexpressed in undifferentiated hematopoietic cells
por: Chen, W.L., et al.
Publicado: (2015)

A Gene Expression and Pre-mRNA Splicing Signature That Marks the Adenoma-Adenocarcinoma Progression in Colorectal Cancer
por: Pesson, Marine, et al.
Publicado: (2014)

HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast
por: Bièche, Ivan, et al.
Publicado: (2021)

Genomic Instability Signature of Palindromic Non-Coding Somatic Mutations in Bladder Cancer
por: Vacher, Sophie, et al.
Publicado: (2020)

Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancer
por: Le Goux, Constance, et al.
Publicado: (2020)

Overexpression of Rad51C splice variants in colorectal tumors
por: Kalvala, Arjun, et al.
Publicado: (2014)

Elucidation of the Signatures of Proteasome-Catalyzed Peptide Splicing
por: Paes, Wayne, et al.
Publicado: (2020)

Alternative splicing signatures in preimplantation embryo development
por: Tian, Geng G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_belg49mjrk2v9ja21ovc1hg03s